Cancer screening startup Ezra secures $4M

By staff writers

November 15, 2018 -- Cancer screening startup Ezra of New York City has secured $4 million in funding, which it plans to use to launch a prostate cancer screening program.

The funding round, led by venture capital firm Accomplice, is also supported by investors Credo Ventures, Esther Dyson, Founders Future, and Seedcamp, the company said.

The program will offer men the opportunity to get prostate MRI scans and have them analyzed by radiologists from imaging services provider RadNet's Lenox Hill Radiology facility in Manhattan. It is currently an invite-only program that costs participants $999 per year.

Ezra is also developing Ezra AI, an artificial intelligence (AI) technology designed to help radiologists analyze images. The company plans to seek U.S. Food and Drug Administration (FDA) clearance for the technology in 2019.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking